生物標志物對ARDS預后的評估_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

翁兵兵 ^1,2 , 詹慶元 ² ,  黃絮 ²

1. ;
2. ;

Corresponding?author：

黃絮, Email: huangxu1122@sina.com

Keywords：

DOI：

10.7507/1671-6205.202309070

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 翁兵兵, 詹慶元, 黃絮. 生物標志物對ARDS預后的評估. Chinese Journal of Respiratory and Critical Care Medicine, 2024, 23(8): 587-592. doi: 10.7507/1671-6205.202309070 Copy

1.
2.	Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3 Pt 1): 818-24.
3.
4.
5.
6.	Dong G, Wang F, Xu L, et al. Serum interleukin-18: A novel prognostic indicator for acute respiratory distress syndrome. Medicine (Baltimore). 2019, 98(21): e15529.
7.
8.
9.
10.
11.	Pliyev BK, Menshikov MY. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis. Inflammation. 2010, 33(1): 1-9.
12.
13.
14.
15.
16.	葛均波, 徐永健, 王辰. 內科學. 北京: 人民衛生出版社, 2018: 130-131.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.	Li F, Yin R, Guo Q. Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies. Ther Adv Respir Dis, 2020, 14: 1753466620905274.
32.
33.
34.
35.	Chen J, Lv X, He H, et al. Significance of vascular endothelium growth factor testing in exhaled breath condensate of patients with acute respiratory distress syndrome. Technol Health Care. 2020;28(S1): 347-354.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.	Pehlivanlar-Kucuk M, Kucuk AO, Ozturk CE, et al. The Association Between Serum Uric Acid Level and Prognosis in Critically Ill Patients, Uric Acid as a Prognosis Predictor. Clin Lab. 2018, 64(9): 1491-1500.
46.
47.	Luporini RL, Pott-Junior H, Di Medeiros Leal MCB, et al. Phenylalanine and COVID-19: Tracking disease severity markers. Int Immunopharmacol, 2021, 101(Pt A): 108313.
48.
49.
50.	Tanaka T, Mori M, Tashiro M, et al. Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021, 16;8: 785409.
51.
52.
53.
54.
55.
56.
57.	Ranjeva S, Pinciroli R, Hodell E, et al. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019. EClinicalMedicine. 2021, 34: 100829.
58.
59.
60.
61.
62.
63.
64.
65.

1.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3 Pt 1): 818-24.
3.
4.
5.
6. Dong G, Wang F, Xu L, et al. Serum interleukin-18: A novel prognostic indicator for acute respiratory distress syndrome. Medicine (Baltimore). 2019, 98(21): e15529.
7.
8.
9.
10.
11. Pliyev BK, Menshikov MY. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis. Inflammation. 2010, 33(1): 1-9.
12.
13.
14.
15.
16. 葛均波, 徐永健, 王辰. 內科學. 北京: 人民衛生出版社, 2018: 130-131.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31. Li F, Yin R, Guo Q. Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies. Ther Adv Respir Dis, 2020, 14: 1753466620905274.
32.
33.
34.
35. Chen J, Lv X, He H, et al. Significance of vascular endothelium growth factor testing in exhaled breath condensate of patients with acute respiratory distress syndrome. Technol Health Care. 2020;28(S1): 347-354.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45. Pehlivanlar-Kucuk M, Kucuk AO, Ozturk CE, et al. The Association Between Serum Uric Acid Level and Prognosis in Critically Ill Patients, Uric Acid as a Prognosis Predictor. Clin Lab. 2018, 64(9): 1491-1500.
46.
47. Luporini RL, Pott-Junior H, Di Medeiros Leal MCB, et al. Phenylalanine and COVID-19: Tracking disease severity markers. Int Immunopharmacol, 2021, 101(Pt A): 108313.
48.
49.
50. Tanaka T, Mori M, Tashiro M, et al. Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021, 16;8: 785409.
51.
52.
53.
54.
55.
56.
57. Ranjeva S, Pinciroli R, Hodell E, et al. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019. EClinicalMedicine. 2021, 34: 100829.
58.
59.
60.
61.
62.
63.
64.
65.

Previous Article
阿來替尼一線治療晚期ALK融合陽性肺大細胞神經內分泌癌患者一例
Next Article
吡非尼酮和尼達尼布在新型冠狀病毒感染后肺纖維化中的應用進展

Chinese Journal of Respiratory and Critical Care Medicine

生物標志物對ARDS預后的評估

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content